Issuer · CIK 0001534120
AVTX — Avalo Therapeutics, Inc.
Recent filings
- Jun 12, 2026·Form 4·Other$7.7K
AVTX/Avalo Therapeutics, Inc.
Riley Jennifer · Chief Strategy Officer
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other$14.2K
AVTX/Avalo Therapeutics, Inc.
VARKI PAUL · Chief Legal Officer
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other$14.2K
AVTX/Avalo Therapeutics, Inc.
Doyle Mittie · Chief Medical Officer
Mechanical filing
AI thesis skipped - Jun 4, 2026·Form 4·Other—
AVTX/Avalo Therapeutics, Inc.
Lind Kevin Robert · director
Mechanical filing
AI thesis skipped - Jun 4, 2026·Form 4·Other—
AVTX/Avalo Therapeutics, Inc.
Truex Samantha · director
Mechanical filing
AI thesis skipped - Jun 4, 2026·Form 4·Other—
AVTX/Avalo Therapeutics, Inc.
KAPLAN GILLA · director
Mechanical filing
AI thesis skipped - Jun 4, 2026·Form 4·Other—
AVTX/Avalo Therapeutics, Inc.
KANTOFF AARON · director
Mechanical filing
AI thesis skipped - Jun 4, 2026·Form 4·Other—
AVTX/Avalo Therapeutics, Inc.
Heffernan Michael Thomas · director
Mechanical filing
AI thesis skipped - May 26, 2026·Form 4·Other—
AVTX/Avalo Therapeutics, Inc.
Riley Jennifer · Chief Strategy Officer
Mechanical filing
AI thesis skipped - May 26, 2026·Form 4·Other—
AVTX/Avalo Therapeutics, Inc.
Sullivan Christopher Ryan · Chief Financial Officer
Mechanical filing
AI thesis skipped - May 26, 2026·Form 4·Other—
AVTX/Avalo Therapeutics, Inc.
VARKI PAUL · Chief Legal Officer
Mechanical filing
AI thesis skipped - May 26, 2026·Form 4·Other—
AVTX/Avalo Therapeutics, Inc.
Doyle Mittie · Chief Medical Officer
Mechanical filing
AI thesis skipped - May 26, 2026·Form 4·Other—
AVTX/Avalo Therapeutics, Inc.
NEIL GARRY ARTHUR · Chief Executive Officer
Mechanical filing
AI thesis skipped - May 19, 2026·Form 4·Sell$56.3K
AVTX/Avalo Therapeutics, Inc.
Doyle Mittie · Chief Medical Officer
8conviction - May 11, 2026·Form 4·Sell$448.8K
AVTX/Avalo Therapeutics, Inc.
Sullivan Christopher Ryan · Chief Financial Officer
22conviction - May 7, 2026·Form 4·Other$839.4K
AVTX/Avalo Therapeutics, Inc.
VARKI PAUL · Chief Legal Officer
12conviction - May 7, 2026·Form 4·Other$377.9K
AVTX/Avalo Therapeutics, Inc.
Sullivan Christopher Ryan · Chief Financial Officer
8conviction - May 7, 2026·Form 4·Other$985.5K
AVTX/Avalo Therapeutics, Inc.
Doyle Mittie · Chief Medical Officer
18conviction - May 7, 2026·Form 4·Sell$72.5K
AVTX/Avalo Therapeutics, Inc.
Chan Mitchell · director
28conviction